Essilorluxottica (Essilorluxottica) Risk Assessment

View and export this data going back to 2004. Start your Free Trial

What is Essilorluxottica Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Essilorluxottica is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Essilorluxottica's Risk Assessment

For the Medical Instruments & Supplies subindustry, Essilorluxottica's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Essilorluxottica's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Essilorluxottica's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Essilorluxottica's Risk Assessment falls into.

Essilorluxottica (OTCPK:ESLOY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Essilorluxottica Risk Assessment Related Terms

Thank you for viewing the detailed overview of Essilorluxottica's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Essilorluxottica (Essilorluxottica) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Essilorluxottica (OTCPK:ESLOY) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

ESLOF:USA EL:Italy ELp:UK 0OMK:UK EL:France ESL:Germany ESLC:Germany ESL:Germany ESL:Germany ESL:Germany EI:Austria

Address

147, Rue de Paris, Charenton-Le-Pont, Paris, FRA, 94220

Website

https://www.essilorluxottica.com

EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest player in their respective fields and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 36% of sales in Europe, 47% in North America, and the rest in Asia and Latin America.

Essilorluxottica (Essilorluxottica) Headlines

From GuruFocus

Dan Loeb Buys David Herro Stock EssilorLuxottica

By Holly LaFon Holly LaFon • 08-26-2019

Daniel Loeb Comments on EssilorLuxottica

By Sydnee Gatewood Sydnee Gatewood • 04-22-2020

TOCQUEVILLE ASSET MANAGEMENT L.P. Cuts Portfolio Down to Size in 1st Quarter

By GuruFocus Research GuruFocus Editor • 05-19-2022

As Myopia Rates Rise in the U.S., Essilor of America Launches Initiative to Help Combat Growing Vision Issue

By PRNewswire PRNewswire • 09-20-2018

Chris Davis Comments on Essilor International SA

By Vera Yuan Vera Yuan • 09-09-2014

Daniel Loeb Comments on EssilorLuxottica

By Sydnee Gatewood Sydnee Gatewood • 10-24-2019